AMETEK (NYSE:AME) Announces Quarterly Earnings Results, Beats Estimates By $0.10 EPS

AMETEK (NYSE:AME) posted its quarterly earnings results on Tuesday. The technology company reported $2.21 EPS for the quarter, topping analysts’ consensus estimates of $2.11 by $0.10, Zacks reports. The business had revenue of $2.22 billion during the quarter, compared to analysts’ expectations of $2.12 billion. AMETEK had a net margin of 19.91% and a return on equity of 17.12%. The business’s quarterly revenue was up 17.3% on a year-over-year basis. During the same period last year, the company posted $1.89 earnings per share.

Here are the key takeaways from AMETEK’s conference call:

• Record third-quarter performance: Sales rose 17% to $2.22 billion, organic sales increased 10%, adjusted EPS grew 17% to $2.21, and free cash flow reached a record $527 million. Core operating margins expanded 110 basis points to 27.3%, supported by productivity and favorable pricing.
• Demand and backlog remain strong: Organic orders increased 17%, with September producing a record monthly order level, and backlog reached $4.54 billion, up 27% from the start of the year. Strength was broad-based, particularly in aerospace and defense, semiconductor, automation, power, and process instrumentation.
• Full-year guidance was raised: AMETEK now expects 2026 sales growth in the mid-teens, organic sales growth in the high-single digits, and adjusted EPS of $8.53-$8.57, up from its prior $8.20-$8.30 forecast. Fourth-quarter EPS is expected to rise 12%-14% to $2.26-$2.30.
• Indicor integration is progressing: The acquisition contributed more than $100 million of third-quarter revenue and approximately $0.08 of expected 2026 EPS accretion. Management is targeting 10%-12% synergies over three years, while the transaction increased debt and quarterly interest expense by $17 million year over year.
• Acquisition strategy remains active: Management said there will be no pause in M&A, citing a robust pipeline and $2.7 billion of cash and available credit capacity. Executives also highlighted continued momentum in commercial aerospace, defense, semiconductor markets, medical technology, and Asia, although Europe remains comparatively weak.

AMETEK Stock Down 4.5%

Shares of NYSE AME opened at $237.29 on Thursday. The stock has a market capitalization of $54.39 billion, a P/E ratio of 33.47, a P/E/G ratio of 2.35 and a beta of 0.96. The company has a 50-day moving average price of $243.65 and a 200-day moving average price of $234.51. AMETEK has a 1 year low of $188.47 and a 1 year high of $261.16. The company has a debt-to-equity ratio of 0.52, a current ratio of 1.43 and a quick ratio of 0.76.

Insider Activity at AMETEK

In related news, insider David Hermance sold 6,608 shares of the company’s stock in a transaction dated Friday, August 7th. The shares were sold at an average price of $254.00, for a total value of $1,678,432.00. Following the sale, the insider owned 42,509 shares in the company, valued at $10,797,286. This represents a 13.45% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 0.54% of the stock is currently owned by insiders.

AMETEK News Roundup

Here are the key news stories impacting AMETEK this week:

• Positive Sentiment: Third-quarter EPS of $2.21 beat estimates, while revenue of $2.22 billion exceeded expectations and rose 17.3% year over year. Organic sales growth, margin expansion and a record backlog supported the company’s higher 2026 earnings and free-cash-flow guidance. AMETEK Q3 Earnings Beat Estimates on Organic Sales & Margin Gains
• Positive Sentiment: RBC raised its price target to $308 from $291 and maintained an Outperform rating, signaling continued confidence in AMETEK’s prospects. RBC Raises Price Target on AMETEK
• Neutral Sentiment: Analyst moves were mixed: Citi lifted its target to $270 but kept a Neutral rating, while Mizuho cut its target to $275 from $285 but retained Outperform. Mizuho Adjusts Price Target on AMETEK
• Negative Sentiment: AME declined despite the earnings beat and raised outlook. The reaction suggests strong results may already have been reflected in expectations, or investors used the report to take profits; coverage focused on the disconnect between record results and the share-price drop. Why Did AMETEK Stock Fall After Record Results and Raised Guidance?

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on AME. Mizuho dropped their price objective on shares of AMETEK from $285.00 to $275.00 and set an “outperform” rating on the stock in a report on Wednesday. BMO Capital Markets boosted their target price on AMETEK from $262.00 to $282.00 in a research report on Wednesday, August 5th. DA Davidson set a $285.00 target price on AMETEK in a research report on Wednesday, October 7th. Zacks Research raised AMETEK from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, October 6th. Finally, TD Cowen reiterated a “buy” rating on shares of AMETEK in a report on Thursday, August 6th. One research analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $278.06.

AMETEK Company Profile

AMETEK, Inc is a global manufacturer of industrial technology solutions. The company develops and produces advanced analytical, monitoring, testing, and measurement instruments, as well as engineered electromechanical products used in industrial, aerospace, defense, energy, medical, and other specialized markets.

AMETEK operates through two primary business groups: Electronic Instruments and Electromechanical. Its products include process and power monitoring systems, analytical instruments, automation and control technologies, aerospace and defense equipment, precision motion-control systems, motors, thermal-management solutions, engineered materials, and specialty metal products.

The company traces its roots to 1930 and has expanded through the development and acquisition of specialized technology businesses.